What are the Historical Developments and Current Growth Metrics of the Tumor Ablation Market?
The tumor ablation market has seen considerable growth due to a variety of factors.
• The tumor ablation market has grown rapidly in recent years. It will rise from $1.45 billion in 2024 to $1.62 billion in 2025, at a CAGR of 12.1%.
This growth is driven by advancements in ablation techniques, increasing healthcare expenditure in emerging economies, the aging population, the growing cancer burden, and the rising global cancer prevalence.
What Does Future Hold for The Tumor Ablation Market By 2029?
The tumor ablation market is expected to maintain its strong growth trajectory in upcoming years.
• The tumor ablation market is projected to grow to $2.54 billion by 2029, at a CAGR of 11.8%.
The growth is attributed to the increasing incidence of cancer, the rise of minimally invasive procedures, expanding applications, cost-effectiveness in healthcare, and greater awareness. Trends include technological advancements, AI integration, outpatient settings focus, and patient-centric approaches.
What Are The Primary Growth Drivers In The Tumor Ablation Market?
The surge in minimally invasive procedures is anticipated to spur the progression of the tumor ablation market. These procedures, which necessitate small or no incisions, are gaining in popularity due to their shortened recovery time, reduced risk of complications, and less post-operative discomfort compared to regular surgeries. Tumor ablation forms part of these procedures by eliminating cancerous tissues via methods such as radiofrequency, microwave, or cryoablation, with minimal damage to the nearby healthy tissues and further shortening of recovery duration. For example, in January 2024, Intuitive Surgical Inc., producing robotic items in the US, stated that they had positioned 415 da Vinci surgical systems (robotic surgical systems adopting a minimally invasive surgical method) in the final quarter of 2023, demonstrating a 12% rise compared to 2022. Therefore, the rise in minimally invasive procedures demonstrates a contributing factor to the market growth of tumor ablation.
What Is The Segmentation Of The Global Tumor Ablation Market?
The tumor ablation market covered in this report is segmented –
1) By Type: Thermal Ablation, Chemical Ablation
2) By Types Of Treatment: Percutaneous, Laparoscopic, Surgical
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Cancer
4) By End Users: Hospitals, Oncology Centers, Other End Users
Subsegments:
1) By Thermal Ablation: Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Cryoablation, Laser Ablation, High-Intensity Focused Ultrasound (HIFU)
2) By Chemical Ablation: Ethanol Ablation, Acetic Acid Ablation, Chemotherapy-Based Ablation (Chemoembolization)
Pre-Book The Tumor Ablation Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Tumor Ablation Market?
Leading firms in the tumor ablation market are working on cutting-edge products like bone tumor ablation systems to increase treatment efficiency, boost patient results, and accommodate more types of tumors. The bone tumor ablation system is a distinct medical instrument used for treating bone tumors using minor surgical procedures. For example, in March 2024, Medtronic plc, a medical device firm based in Ireland, acquired U.S. Food and Drug Administration (FDA) 510(k) clearance for its OsteoCool 2.0 bone tumor ablation system. This advanced system is engineered to treat painful bone metastases and benign bone tumors such as osteoid osteoma. The OsteoCool 2.0 has the capacity for the concurrent use of four internally cooled probes, allowing doctors to ablate two vertebral bodies concurrently or create larger ablation areas in non-spinal applications. With a delivery of 20W per channel, it has over double the power of the Stryker OptaBlate bone tumor ablation system.
Who Are the Key Players In The Tumor Ablation Market?
Major companies operating in the tumor ablation market are:
• Abbott Laboratories
• Medtronic plc
• Siemens Healthineers AG
• Stryker Corporation
• Boston Scientific Corporation
• Olympus Corporation
• Terumo Corporation
• Varian Medical Systems Inc.
• Merit Medical Systems Inc.
• Bioventus LLC
• Accuray Incorporated
• AtriCure Inc.
• AngioDynamics Inc.
• EDAP TMS S.A.
• NeuWave Medical Inc.
• Mirabilis Medical Inc.
• STARMed Co. Ltd.
• Profound Medical Corp.
• RF Medical Co. Ltd.
• IceCure Medical Ltd.
• MedWaves Inc.
• Chongqing Haifu Medical Technology Co. Ltd.
What Are The Regional Insights Into The Tumor Ablation Market?
North America was the largest region in the tumor ablation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
